Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anu Singh Maharjan"'
Autor:
Ajay P. Singh, Anu Singh Maharjan, Cindy Nelson, Peter J. Hosein, Moh’d Khushman, Gwendolyn A. McMillin, Girijesh Kumar Patel
Publikováno v:
The Pharmacogenomics Journal
Introduction The prevalence of 2R/2R TYMS genotype is variable but estimated to be around 20–30% in Caucasians. The clinical relevance of TYMS 2R/2R genotype in predicting severe fluoropyrimidine-related adverse events (FrAE) is controversial. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629795bf4aa862a0449eedbdb871a03d
https://pubmed.ncbi.nlm.nih.gov/33608662
https://pubmed.ncbi.nlm.nih.gov/33608662
Autor:
Peter J. Hosein, Girijesh Kumar Patel, Ajay P. Singh, William R. Taylor, Bin Wang, Gwendolyn A. McMillin, Sachin Pai, Arthur E. Frankel, Moh’d Khushman, Anu Singh Maharjan, Cindy Nelson, Saad Awan
Publikováno v:
Clinical colorectal cancer. 18(3)
Introduction The dihydropyrimidine dehydrogenase gene (DPYD)*9A (c.85T>C) genotype is relatively common. The correlation between DPYD*9A genotype and dihydropyrimidine dehydrogenase (DPD) deficiency phenotype is controversial. In a cohort of 28 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb610b93269783ae7f269b376b66a02
https://pubmed.ncbi.nlm.nih.gov/31160238
https://pubmed.ncbi.nlm.nih.gov/31160238
Immunoassays are widely used for screening urine specimens for possible presence of illicit drugs. However, immunoassays suffer from interferences and as a result initially screened positive specimens should be confirmed by a more sophisticated analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa836f66684fafa6d94c51c26f569fb
https://doi.org/10.1016/b978-0-12-815607-0.00010-1
https://doi.org/10.1016/b978-0-12-815607-0.00010-1
Publikováno v:
American Journal of Clinical Pathology. 150:S163-S164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbdca3f92714b9280aef2cfa09180ed
https://doi.org/10.1093/ajcp/aqy112.379
https://doi.org/10.1093/ajcp/aqy112.379
Autor:
Jonathan R. Genzen, Julie A. Ray, Jonathan D. Seiter, Sara P. Wyness, Tanya L. Willcox, Anu Singh Maharjan
Publikováno v:
Practical Laboratory Medicine
Practical Laboratory Medicine, Vol 17, Iss, Pp-(2019)
Practical Laboratory Medicine, Vol 17, Iss, Pp-(2019)
Objectives Competitive immunoenyzmatic assays for estradiol (E2) and unconjugated estriol (uE3) on UniCel DxI 800 Access immunoassay systems (Beckman Coulter) utilize bovine alkaline phosphatase (ALP) for amplification. In these assays, rare ‘IND
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::293a9338caa9c63f05b9de882fe99f26
https://doi.org/10.1016/j.plabm.2019.e00131
https://doi.org/10.1016/j.plabm.2019.e00131
Autor:
Girijesh Kumar Patel, Anu Singh Maharjan, Spencer Liles, Gwendolyn A. McMillin, Leander Grimm, Bin Wang, Peter J. Hosein, Paul Rider, William R. Taylor, Arthur E. Frankel, John Hunter, Moh’d Khushman, Clayton Smith, Cindy Nelson, Saad Awan, Sachin Pai, Ajay P. Singh
Publikováno v:
Journal of Clinical Oncology. 37:545-545
545 Background: Fluoropyrimidines are antimetabolites that target the S phase of the cell cycle. The active metabolite, 5-fluorodeoxyuridine monophosphate inhibits thymidylate synthase (TS) enzyme, thus preventing DNA synthesis and ultimately cell de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ac4d0db2344d1a855bdd752dd9634c5
https://doi.org/10.1200/jco.2019.37.4_suppl.545
https://doi.org/10.1200/jco.2019.37.4_suppl.545
Autor:
Ajay P. Singh, William R. Taylor, Girijesh Kumar Patel, Gwendolyn A. McMillin, Anu Singh Maharjan, Moh’d Khushman, Peter J. Hosein, Cindy Nelson, Saad Awan, Sachin Pai, Arthur E. Frankel, Bin Wang
Publikováno v:
Journal of Clinical Oncology. 37:544-544
544 Background: The correlation between DPYD*9A (c.85T > C) genotype and dihydropyrimidine dehydrogenase (DPD) deficiency phenotype is controversial. In our cohort of 28 patients with gastrointestinal malignancies (GI) treated with fluoropyrimidines,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cf6733513b8fad06abb744a7b4db54a
https://doi.org/10.1200/jco.2019.37.4_suppl.544
https://doi.org/10.1200/jco.2019.37.4_suppl.544